GrowingStockReport.com

Affymax, Inc. (NASDAQ:AFFY) and AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 06/03/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Affymax, Inc. (NASDAQ:AFFY) and AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX).

Affymax, Inc. (NASDAQ:AFFY) a biopharmaceutical company that engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life threatening illnesses is currently down (-18.75%) on 16,688,971 shares traded after Affymax announced paying $6 million to two suppliers of the drug’s ingredients. Affymax, Inc. (NASDAQ:AFFY) is currently down (-94.92%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Affymax, Inc. (NASDAQ:AFFY)

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) a development stage specialty pharmaceutical company that focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain is currently down (-6.85%) on 573,330 shares traded. AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is currently down (-17.48%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com